UCB
The Access & Pricing Strategy Team Lead - Immunology will lead and develop a team while acting as a strategic partner to Asset Payer Heads to shape global payer, access, and pricing strategies. This role integrates payer perspectives into asset development and commercialization planning to maximize patient access and long-term value. The position requires strong leadership, cross-functional collaboration, and expertise in health economics and market access.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
Director, Global Pricing and Market Access Strategy Lead Immunology
Bristol Myers Squibb
Director, Payer & Pricing Strategy
Novartis
Director, Global Market Access, Immunology
MSD
Director, Payer & Pricing Strategy
Novartis
Immunology TA Access Strategy Manager
Novartis
Vice President, Market Access
Mirum Pharmaceuticals